Pessis D - Search Results

Year	Number of Results
1978	1
1981	1
1984	1
1985	1
1986	1
1994	1
2002	2
2008	1
2010	1
2016	1
2017	2
2024	0

1

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.

2

An Atypical Presentation of Retroperitoneal Fibrosis.

Tan WP, Hwang T, Medairos R, Pessis DA. Tan WP, et al. Among authors: pessis da. Curr Urol. 2017 Aug;10(3):157-159. doi: 10.1159/000447172. Epub 2017 Jul 30. Curr Urol. 2017. PMID: 28878601 Free PMC article.

3

Central zone lesions on magnetic resonance imaging: Should we be concerned?

Tan WP, Mazzone A, Shors S, Antoine N, Ekbal S, Khare N, McKiel C, Pessis D, Deane L. Tan WP, et al. Among authors: pessis d. Urol Oncol. 2017 Jan;35(1):31.e7-31.e12. doi: 10.1016/j.urolonc.2016.08.006. Epub 2016 Sep 28. Urol Oncol. 2017. PMID: 27692837

4

A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.

Trachtenberg J, Gittleman M, Steidle C, Barzell W, Friedel W, Pessis D, Fotheringham N, Campion M, Garnick MB; Abarelix Study Group. Trachtenberg J, et al. Among authors: pessis d. J Urol. 2002 Apr;167(4):1670-4. doi: 10.1097/00005392-200204000-00021. J Urol. 2002. PMID: 11912385 Clinical Trial.

5

Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.

Rovner ES, Rackley R, Nitti VW, Wang JT, Guan Z; 037 Study Group. Rovner ES, et al. Urology. 2008 Sep;72(3):488-93. doi: 10.1016/j.urology.2008.05.019. Epub 2008 Jul 17. Urology. 2008. PMID: 18639327 Clinical Trial.

6

Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture.

Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC. Patterson BK, et al. Among authors: pessis d. Am J Pathol. 2002 Sep;161(3):867-73. doi: 10.1016/S0002-9440(10)64247-2. Am J Pathol. 2002. PMID: 12213715 Free PMC article.

7

Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.

Bonomi P, Pessis D, Bunting N, Block M, Anderson K, Wolter J, Rossof A, Slayton R, Harris J. Bonomi P, et al. Among authors: pessis d. Semin Oncol. 1985 Mar;12(1 Suppl 1):36-9. Semin Oncol. 1985. PMID: 3975650

8

Treatment of stage D prostatic carcinoma with megestrol acetate.

Block M, Bonomi P, Anderson K, Wolter J, Showel J, Pessis D, Slayton R. Block M, et al. Among authors: pessis d. J Surg Oncol. 1981;17(4):367-71. doi: 10.1002/jso.2930170409. J Surg Oncol. 1981. PMID: 7265976

9

MR imaging of xanthogranulomatous pyelonephritis.

Mulopulos GP, Patel SK, Pessis D. Mulopulos GP, et al. Among authors: pessis d. J Comput Assist Tomogr. 1986 Jan-Feb;10(1):154-6. doi: 10.1097/00004728-198601000-00037. J Comput Assist Tomogr. 1986. PMID: 3944304

10

Cellular immunity in bladder cancer patients.

Guinan P, McKiel C, Flanagan M, Bhatti R, Pessis D, Ablin RJ. Guinan P, et al. Among authors: pessis d. J Urol. 1978 Jun;119(6):747-9. doi: 10.1016/s0022-5347(17)57620-x. J Urol. 1978. PMID: 660759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year